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Abstract
Background: Gastrointestinal autonomic nerve tumours are uncommon stromal tumours of the
intestinal tract. They can involve any part of the gastrointestinal system, but are very rarely seen in
the rectum.
Case presentation: We report a unique case of rectal schwannoma with associated synchronous
adenocarcinoma of the splenic flexure and adenoma of the descending colon. A 70-year-old patient
was admitted with complaint of bleeding per rectum and investigations revealed the presence of a
large submucosal rectal lesion in addition to the colonic pathologies. Following
panproctocolectomy with permanent spout ileostomy, histopathology and immunohistochemistry
confirmed the rectal lesion to be a schwannoma.
Conclusion: Literature review of the few reported cases has suggested radical surgical excision
to be the best approach. Prognosis tends to be favourable after resection.
Background
The gastrointestinal autonomic nerve tumours (GANTs)
were first described and defined by Herrera et al, in 1984
[1]. GANTs are uncommon stromal tumours accounting
for 0.1% of benign tumours of the gastrointestinal tract
[2]. It is a subgroup of gastrointestinal stromal tumours
(GISTs) with specific ultrastructural differences; suggest-
ing its origin from the myenteric plexus [3]. Schwanno-
mas belong to this group and may develop practically in
any anatomic region [2].
Without immunohistochemical studies, Schwannomas
are often misdiagnosed as leiomyomas or leiomyosarco-
mas and generally present as an asymptomatic mass and/
or with non-specific symptoms of fatigue and prolonged
pain as well as signs of low grade pyrexia, anaemia and
haemorrhage. Conventional pathological techniques are
usually not diagnostic [2]; electron microscopy often
being required to establish the diagnosis of GANTs and to
exclude them from other gastrointestinal tumours [4].
Common sites for GANTs include the stomach, duode-
num, jejunum, ileum [5] and to date literature search has
revealed only twenty cases of colonic schwannomas and
only four reported cases of rectal schwannomas [2,6-9].
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World Journal of Surgical Oncology 2005, 3:46 http://www.wjso.com/content/3/1/46We report a rare case of rectal schwannoma who also had
incidental adenocarcinoma and adenoma of the colon.
Case presentation
A 70-year-old gentleman presented with a two-month his-
tory of bleeding per rectum and altered bowel habits.
There was no history of tenesmus but sensation of incom-
plete evacuation following defecation as well as a feeling
of a lump in the anal canal was present. His appetite and
weight had been stable.
Clinically he looked well and abdominal examination
revealed no abnormality. Per rectal examination revealed
a mass in the posterior wall of the rectum with intact
mucosa, which had significantly narrowed the lumen.
Colonoscopy revealed the presence of a mass in the pos-
terolateral wall of the rectum extending from 4 to 14 cm
from the anal verge, with normal overlying mucosa. In
addition, there was also a large sessile polyp in the
descending colon and an ulceroproliferative growth at the
splenic flexure; histopathology confirmed adenomatous
polyp and adenocarcinoma respectively.
Computerised tomography (CT) of the pelvis showed
thickening of the distal rectum with an obvious low den-
sity poorly enhancing lesion with possible calcification in
its wall. Tissue plane between this lesion and prostate was
not clearly seen but there was no infiltration of the
ischiorectal fat (Figure 1a). Magnetic resonance imaging
(MRI) showed a very large well-defined mass in the left
presacral / ischio-anal fossa contiguous with rectal wall
and thus almost certainly arising from one of the elements
of the rectal wall (Figure 1b). Barium enema showed an
apple core lesion in the splenic flexure (Figure 2a) as well
as narrowing of the distal rectal lumen (Figure 2b).
The case was fully discussed at the colorectal multidisci-
plinary team meeting and all the surgical options includ-
ing left hemicolectomy combined with
rectosigmoidectomy plus transverse colostomy were fully
evaluated. However, the consensus was that the addi-
tional presence of an adenocarcinoma as well as an ade-
noma higher up in the colon combined with the size of
rectal schwannoma (12 cms) made panproctocolectomy
with permanent ileostomy the best viable option. Further-
more, this was also the preferred choice of the patient as
he opted to have an ileostomy rather than a colostomy.
Surgery was performed without complications and the
postoperative recovery was uneventful. At 6 months fol-
low-up, the patient remains asymptomatic.
Macroscopic examination of the resected specimen con-
firmed the malignant tumour in the splenic flexure, the
polyp in the descending colon and a 10 × 12 cm tumour
with a well-defined pseudocapsule in the postero-lateral
wall of the mid and low rectum (Figure 3). The surface of
the latter lesion was fusiform with bluish-grey colour and
its cut surface was irregularly lobulated with occasional
cystic and necrotic areas.
Imaging of the large bowel 1a) CT scan showing the large lesion in the posterior and left lateral wall of the rectum and 1b) MRI i : the distal rectal wall lesion (GANT) is shown to be intramural and free from adjoining structuresFigure 1
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invasive moderately differentiated adenocarcinoma (G1;
Dukes B; Stage2). The polyp further down the colon was a
tubulovillous adenoma with moderate focal dysplasia.
The rectal tumour showed irregularly running fascicles of
spindly to plump mesenchymal cells. The tumour was
fairly vascularised with presence of a number of dilated
and engorged vessels. The mitotic count was 4 per high
power field. Some parts of the tumour were quite cellular
while few areas were hypocellular reminiscent of the
Antoni A and Antoni B patterns respectively (Figures 4a
and 4b). Immunostaining revealed strong reactivity for
neuron specific enolase (NSE), vimentin, CD34 and focal
positivity for S100 (Figures 5a, 5b, 5c and 5d). Smooth
muscle markers actin and desmin were negative.
Discussion
Gastrointestinal autonomic nerve tumours represent a
distinct but rare subcategory of gastrointestinal stromal
tumours accounting for 1% of all malignant gastrointesti-
nal tumours. Initially described as plexosarcomas, these
tumours have been reported to be more common in males
and have a wide spectrum of age range [5]. Literature
review has shown rare association of GANTs with neurofi-
bromatosis [10-12] and adrenal ganglioneuroma [13].
Schwannomas are types of gastrointestinal tract auto-
nomic tumours and amongst this group, rectal schwanno-
mas are very rare [13,14]. Furthermore, the case described
here, was associated with adenocarcinoma and adenoma
of the colon (Figure 3) and to date, there has been no
reports of a similar association. Chance or an epigenetic
event could explain such association of the different syn-
chronous lesions.
Conventional imaging modalities such as barium enema,
colonoscopy, computerised tomography and MRI have
been used to investigate these patients but there are no
definite radiological criteria to differentiate benign from
malignant stromal tumour [15]. As shown in Figures 1a
and 1b, CT and MRI scans located the large encapsulated
lesion as arising from the rectal musculature, but yielded
no additional information which allow for the distinction
of benign from malignant potential. Recently Levy et al,
[16] have reported that CT imaging may help to differen-
tiate GANTs from gastrointestinal stromal tumours
(GISTs). Low attenuation features (indicative of haemor-
rhage, necrosis and degeneration typically found in the
centre of the GISTs) was not seen in our case (Figure 1a);
thus favouring GANTs. Endoscopic ultrasound has been
suggested to be reliable in predicting malignancy and the
predictive features being irregular margins, depth of pen-
etration, cystic spaces and lymph nodes with a malignant
pattern [17]. However, it does not differentiate GANTs
from the other stromal tumours [15]. Endoscopic ultra-
sound guided fine needle aspiration with
immunohistochemical analysis may be useful in the pre-
operative diagnosis of GIST [18] but in our patient, this
was not done, as it would not have altered the treatment,
Barium enema a) the apple core lesion at the splenic flexure and b) the extrinsic compression in the distal rectum caused by schwannomaFig re 2
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and also the size of the lesion.
Although GANTs do exhibit a variety of specific histolog-
ical features, Lauwers et al, [10] believe that neither indi-
vidual cell characteristics nor the growth pattern of these
tumours allow distinction from GISTs. The differentiation
of schwannomas from other stromal tumours is impor-
tant because the latter group has high-risk of malignant
behaviour [19]. Furthermore, whilst some authors disa-
gree [5], others have suggested the presence of both
Antoni A / Verocay bodies (cells forming a typical palisade
arrangement in a well-organised pattern) and Antoni B
(small lacunar foci with loss of palisade architecture)
areas to be very specific for schwannoma [20]. Such pat-
terns have been clearly demonstrated in our case (Figures
4a and 4b).
Immunohistochemical studies of GANTs have usually
demonstrated positivity to vimentin, CD34 and CD117
[5,10,21]. Positive reactivity with neuron specific enolase
(NSE), S-100 protein, synaptophysin, and chromogranin
A (proteins expressed by neurons from the autonomic
nerve plexus) have also been reported and this support the
histogenesis of GANTs from the autonomic plexus of
Meissner or Auerbach [5]. Furthermore, positive immuno-
reactivity to the S-100 protein and Leu7 antigen tend to
indicate the Schwannian nature of the tumour [22],
whereas positivity to the glial fibrillary acidic protein
point towards a myenteric plexus origin [3]. GANT is an
ultrastructural variant of GIST, based on its consistent
Resected specimen showing malignant tumour at the splenic flexure, polyp in the descending colon and rectal schwannomaFigure 3
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World Journal of Surgical Oncology 2005, 3:46 http://www.wjso.com/content/3/1/46CD117 positivity and the presence of GIST-specific c-kit
gene mutations in a significant number of cases [23]. The
published GANT tumours have been variably and incon-
sistently S-100 protein positive. In our patient, immuno-
histochemistry revealed reactivity for vimentin, NSE,
CD34 and for S-100 (Figure 5). Desmin and actin were
negative.
Whilst immunohistochemistry provides important diag-
nostic differentiation of GANTs from other stromal
tumours, definitive diagnosis can only be based on
ultrastructural studies [5]. The ultrastructural criteria that
suggest origin from myenteric plexus are neuron-like cells
with long cytoplasmic processes containing microtubules,
bulbous synapse like structures with dense core neurose-
cretory type granules and empty vesicles [10]. Ultrastruc-
tural examination is not available at most pathological
units (including ours); this could explain the paucity of
these cases and it is suggested that representative samples
should be sent to centres having electron microscopic
facilities.
The exact biological behaviour of GANTs is not yet fully
elucidated due to the limited number of reported cases
and as a result, determination of malignancy poses a dif-
ficult challenge, which cannot always be resolved by con-
ventional histopathology. Various parameters have been
studied in relation to tumour behaviour and to date; no
single one is fully predictive of malignancy. Mitotic
activity (counts >5 mitoses per high power fields) and
tumour size (> 5 cm) tend to be associated with a high risk
of metastasis or recurrence [24]. Although GANTs are gen-
erally considered benign, Lauwers et al, reported that 30%
of these patients developed local recurrence [12] and as a
result, radical surgery is the optimal treatment [5]. In our
case, the additional presence of an adenocarcinoma and
adenoma higher up in the colon combined with the size
of the rectal schwannoma (>12 cms) made pan-procto-
colectomy with permanent ileostomy the better option.
The recent finding of CD117 receptors in these tumours
combined with technological advances has led to the
development of anti-tumour agents. Treatment of such
CD117 positive GANTs with tyrosine kinase inhibitors
have been shown to be beneficial [25] and could in future,
represent an appropriate form of palliative therapy in
those patients with unresectable as well as metastatic
tumours [5].
Conclusion
Further studies are required not only to fully characterise
the molecular biology of these tumours but also their
aggressiveness as there is an inherent difficulty in making
a benign diagnosis in GANTs. This is clearly important
since it may result in a poor cross over in the assessment
of the responsiveness of GANTs to anti-CD117 treatment.
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